We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from... Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder. Show more
Latest expansion to the CORI◊ Surgical System portfolio provides a personalized solution for patients and surgeons Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has received 510(k) clearance from the United States Food & Drug Administration for a stemless...
Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, is proud to announce that its RENASYS EDGE Negative Pressure Wound Therapy (NPWT) System has won the Red Dot Award for...
Patented technology further personalizes total knee arthroplasty for surgeons and patients Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has signed a...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company announced today that its LEGION Hinged Knee (HK) System is now available in the United States with proprietary OXINIUM...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces promising surgeon feedback from the first completed cases utilizing its new CATALYSTEM Primary Hip System...
New TOTAL ANKLE Patient-Matched Guides pair with Smith+Nephew’s Total Ankle replacement solution, designed to help surgeons save time and ensure accuracy while performing fewer steps than standard...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of its TOTAL ANKLE Patient-Matched Guides, giving surgeons a predictable and efficient option to...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.96 | -3.74707259953 | 25.62 | 25.7 | 24.655 | 517372 | 25.16693779 | DR |
4 | -0.56 | -2.22045995242 | 25.22 | 25.98 | 24.655 | 614226 | 25.43651165 | DR |
12 | -6.25 | -20.2199935296 | 30.91 | 31.355 | 23.85 | 776375 | 26.59815884 | DR |
26 | -0.55 | -2.18167393891 | 25.21 | 31.72 | 23.85 | 758431 | 27.81534188 | DR |
52 | -2.23 | -8.29304574191 | 26.89 | 31.72 | 23.65 | 839144 | 26.97979475 | DR |
156 | -7.61 | -23.5822745584 | 32.27 | 36.68 | 21.525 | 928680 | 27.46331313 | DR |
260 | -23.3 | -48.5821517932 | 47.96 | 52.26 | 21.525 | 780130 | 30.99830346 | DR |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions